title: Current status of FK 506 in liver transplantation.
authors.affiliation: Department of Surgery, University of Pittsburgh School of Medicine, Pennsylvania 15213.
authors.forename: J J
authors.initials: JJ
authors.lastname: Fung
authors.forename: S
authors.initials: S
authors.lastname: Todo
authors.forename: A
authors.initials: A
authors.lastname: Tzakis
authors.forename: M
authors.initials: M
authors.lastname: Alessiani
authors.forename: K
authors.initials: K
authors.lastname: Abu-Elmagd
authors.forename: A
authors.initials: A
authors.lastname: Jain
authors.forename: O
authors.initials: O
authors.lastname: Bronster
authors.forename: M
authors.initials: M
authors.lastname: Martin
authors.forename: R
authors.initials: R
authors.lastname: Gordon
authors.forename: T E
authors.initials: TE
authors.lastname: Starzl
mesh_terms: D000410:Alanine Transaminase / Q000097:blood; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001219:Aspartate Aminotransferases / Q000097:blood; D001663:Bilirubin / Q000097:blood; D006084:Graft Rejection; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016031:Liver Transplantation / Q000379:methods*; D016019:Survival Analysis; D016559:Tacrolimus
chemical_list: D000900:Anti-Bacterial Agents; D007166:Immunosuppressive Agents; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D001663:Bilirubin; D016559:Tacrolimus